ALK and neuroblastoma: We show complete maintained responses to CDX0239-PBD in NB-SD, COG-N-424x, and NGP, xenografts that do not harbor ALK gene amplification and exhibit ALK surface expression representative of the majority of neuroblastoma tumors and relevant xenograft models60.